DEDICA (Dose of HEparin During Coronary Angioplasty) Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1000 participants.

Also called NCT01694459

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01694459
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01694459. Randomized; single masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2012-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
DEDICA (Dose of HEparin During Coronary Angioplasty) Trial
Acronym
DEDICA
Condition
Stable Angina
Condition
Angina, Unstable
Condition
Non-ST Elevation (NSTEMI) Myocardial Infarction
Intervention (Drug)
Low-dose heparin
Intervention (Drug)
Standard dose heparin
Lead sponsor
San Filippo Neri General Hospital (class: other)
Collaborator
University of Roma La Sapienza (class: other)

Record details

Record id
cardio:ct-nct01694459
Content hash
7c52f0b6bbef32ff1d8e6c86ba0eb4a717fe17cfcbe47f0918b42c0e37e602d8